Abstract Library

#4555 Assessment of gastric mucosa conditions changes in patients with gastric neuroendocrine neoplasia type 1 during gastroprotective therapy

Introduction: Currently, the incidence of gastric neuroendocrine neoplasia (gNEN) has increased significantly. Most gNEN are developed on the background of chronic atrophic gastritis (about 90%). Despite this, the role of chronic atrophic gastritis treatment (gastroprotective therapy) in dynamic of gNEN remains unexplored.

Conference:

Presenting Author: Konyakhina A

Authors: Konyakhina A, Feidorov I, Salimgereeva D, Petrova A,

Keywords: gNEN, atrophic gastritis, OLGA, rebamipide,

#4154 Gastric mucosa conditions during atrophic gastritis and gastric neuroendocrine neoplasia type 1 (gNEN 1)

Introduction: Worldwide frequency of neuroendocrine tumors increased, which is associated with improved approaches to the diagnosis of chronic diseases of the upper digestive tract. Management of these neoplasms in real clinical practice can be difficult.

Conference:

Presenting Author: Konyakhina A

Authors: Konyakhina A, Feidorov I, Salimgereeva D,

Keywords: gNEN, atrophic gastritis, OLGA, rebamipide,

#3437 Is non-operative management of small asymptomatic sporadic nonfunctioning pancreatic neuroendocrine tumors safe?

Introduction: The diagnosis of asymptomatic sporadic nonfunctioning pancreatic neuroendocrine tumors (NF-PNET) has increased significantly nowadays due to the widespread use of high-resolution imaging tests, which is why it is debated which should be the most appropriate management at the time of diagnosis, and how we should follow-up these patients.

Conference:

Presenting Author:

Authors: Polette D, Busquets J, Uribe C, Martínez-Carnicero L, Secanella L,

Keywords: pancreatic neuroendocrine tumor, conservative treatment, observation, small tumor,

#1226 Follow Up of ≤ 2 cm Non Functioning Pancreatic NETs in Patients with MEN1 Treated with Conservative Approach

Introduction: There is a current trend for conservative treatment of non functioning pancreatic NET (NF-PNETs), ≤ 2 cm, in patients with MEN1, which are reported to be associated with low risk of metastasis and death.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Davi' M

Authors: Davì M, Cosaro E, Malpaga A, Butturini G, Ortolani S,

Keywords: Pancreatic neuroendocrine tumor, MEN1,

#774 The Grading of pNENs in MEN-1 Syndrome: Consequences for Tumor Progression and Surgical Strategy?

Introduction: MEN-1 patients develop multiple pNENs. The treatment of choice ranges from watchful waiting to total pancreatectomy. Up to now, the impact of the grading has not been evaluated to either plan surgery or conservative treatment.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Selberherr A

Authors: Selberherr A, Koperek O, Niederle B,

Keywords: MEN-1, pancreas, pNEN,